StepStone Group Portfolio holdings
StepStone Group is a private markets firm that builds customized investment portfolios, monitors them and advises investors. Its business spans primary and secondary fund investments plus co-investments, across private equity, real estate, infrastructure, real assets and private debt. Its founders, Monte Brem and Thomas Keck, had earlier made private equity investments at Pacific Corporate Group, as president and managing director respectively. StepStone went public on the Nasdaq in September 2020. The firm serves institutional investors and sponsors worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sprinklr
CXM
|
+$2.3M |
| 2 |
HilleVax
HLVX
|
+$2.11M |
| 3 |
Freshworks
FRSH
|
+$907K |
| 4 |
Toast
TOST
|
+$855K |
| 5 |
Braze
BRZE
|
+$254K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rocket Lab Corp
RKLB
|
+$24.3M |
| 2 |
Rover Group, Inc. Class A Common Stock
ROVR
|
+$3.16M |
| 3 |
Affirm
AFRM
|
+$1.25M |
| 4 |
Confluent
CFLT
|
+$691K |
| 5 |
HashiCorp, Inc. Class A Common Stock
HCP
|
+$387K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 56.74% |
| 2 | Technology | 31.43% |
| 3 | Healthcare | 7.92% |
| 4 | Communication Services | 3.2% |
| 5 | Industrials | 0.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
DELISTED
Dun & Bradstreet
DNB
| $220M | 52.04% |
22,042,226
| – | – |
2021 Q4
7 quarters
|
|
2
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $98.3M | 23.23% |
10,366,855
| – | – |
2021 Q3
8 quarters
|
|
3
UiPath
PATH
$6.85B
| $31M | 7.33% |
1,813,820
+8,224
| +0.5% | +$137K |
2021 Q3
8 quarters
|
|
4
DELISTED
MoneyLion Inc.
ML
| $16.9M | 3.98% |
779,050
| – | – |
2021 Q3
8 quarters
|
|
5
Roblox
RBLX
$37.7B
| $13.5M | 3.2% |
467,547
-1,505
| -0.3% | -$50K |
2021 Q3
8 quarters
|
|
6
Entrada Therapeutics
TRDA
$213M
| $12M | 2.84% |
761,277
| – | – |
2021 Q4
7 quarters
|
|
|
7
DELISTED
HilleVax
HLVX
| $11.1M | 2.63% |
826,567
+149,998
| +22% | +$2.11M |
2022 Q2
5 quarters
|
|
8
Phathom Pharmaceuticals
PHAT
$511M
| $4.38M | 1.03% |
422,085
| – | – |
2021 Q3
8 quarters
|
|
9
DELISTED
NeueHealth
NEUE
| $3.14M | 0.74% |
525,252
+3
| +0% | +$31 |
2021 Q3
8 quarters
|
|
10
DELISTED
Doma Holdings, Inc.
DOMA
| $3.02M | 0.71% |
595,177
-2
| -0% | -$12 |
2021 Q3
8 quarters
|
|
|
11
Sprinklr
CXM
$1.54B
| $2.22M | 0.53% |
+160,509
| New | +$2.3M |
2023 Q3
0 quarters
|
|
|
NGM
12
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $1.68M | 0.4% |
1,573,357
| – | – |
2021 Q3
8 quarters
|
|
13
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $1.36M | 0.32% |
147,261
| – | – |
2021 Q4
7 quarters
|
|
14
Tenaya Therapeutics
TNYA
$84.6M
| $1.18M | 0.28% |
462,163
| – | – |
2021 Q3
8 quarters
|
|
15
Grove Collaborative
GROV
$45.7M
| $1.01M | 0.24% |
380,383
| – | – |
2022 Q2
5 quarters
|
|
|
16
Toast
TOST
$19.8B
| $737K | 0.17% |
+39,369
| New | +$855K |
2023 Q3
0 quarters
|
|
|
17
Rocket Lab Corp
RKLB
$42.3B
| $461K | 0.11% |
8,206,916
-3,995,180
| -33% | -$24.3M |
2021 Q3
8 quarters
|
|
|
18
Braze
BRZE
$5.28B
| $270K | 0.06% |
+5,779
| New | +$254K |
2023 Q3
0 quarters
|
|
|
19
Freshworks
FRSH
$3.17B
| $236K | 0.06% |
91,293
+45,619
| +100% | +$907K |
2023 Q1
2 quarters
|
|
20
DELISTED
Wag!
PET
| $225K | 0.05% |
+117,976
| New | +$253K |
2023 Q3
0 quarters
|
|
21
DELISTED
Agiliti Inc
AGTI
| $130K | 0.03% |
20,101
| – | – |
2023 Q2
1 quarter
|
|
|
AMRS
22
DELISTED
Amyris Inc.
AMRS
| $1.69K | ﹤0.01% |
2,816
| – | – |
2022 Q4
3 quarters
|
|
|
23
Affirm
AFRM
$23B
| – | – |
-81,445
| Closed | -$1.25M | – |
|
|
24
DELISTED
Confluent
CFLT
| – | – |
-19,558
| Closed | -$691K | – |
|
25
Mirum Pharmaceuticals
MIRM
$6.18B
| – | – |
-4,179
| Closed | -$108K | – |
|
Similar funds
StepStone Group's Q3 2023 Portfolio in Review
As of Q3 2023, StepStone Group held 28 positions worth $423M, down 22% from $541M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
StepStone Group withdrew a net $23.2M in Q3 2023, closing 6 positions and reducing 3 holdings. Its most notable exit was Rover Group, Inc. Class A Common Stock, an estimated $3.16M position sold in full.
By sector, the portfolio is most concentrated in Financials at 57% of assets, up from 50% a quarter earlier, followed by Technology and Healthcare.
Against the trend, StepStone Group opened a new position in Sprinklr worth $2.22M.
- StepStone Group's largest Q3 2023 buy was Sprinklr: 160,509 shares worth $2.22M.
- StepStone Group added most to HilleVax in Q3 2023, an estimated $2.11M increase.
- StepStone Group's biggest Q3 2023 reduction was Rocket Lab Corp, cutting an estimated $24.3M.
- StepStone Group fully exited Rover Group, Inc. Class A Common Stock in Q3 2023, selling an estimated $3.16M.
- StepStone Group's ten largest holdings make up 98% of its $423M portfolio in Q3 2023.
- StepStone Group opened 4 new positions and closed 6 in Q3 2023.
- StepStone Group's portfolio value fell 22% quarter-over-quarter to $423M.
Based on StepStone Group's 13F filing for Q3 2023, filed 13 Nov 2023.